BRPI0408077A - composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições - Google Patents

composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições

Info

Publication number
BRPI0408077A
BRPI0408077A BRPI0408077-7A BRPI0408077A BRPI0408077A BR PI0408077 A BRPI0408077 A BR PI0408077A BR PI0408077 A BRPI0408077 A BR PI0408077A BR PI0408077 A BRPI0408077 A BR PI0408077A
Authority
BR
Brazil
Prior art keywords
compositions
endotoxin
prevention
treatment
conditions
Prior art date
Application number
BRPI0408077-7A
Other languages
English (en)
Inventor
James Mcshane
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of BRPI0408077A publication Critical patent/BRPI0408077A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

"COMPOSIçõES E MéTODOS PARA PREVENçãO E TRATAMENTO DE DOENçAS RELACIONADAS COM ENDOTOXINA E CONDIçõES". A presente invenção provê composições farmacêuticas para a prevenção e tratamento de condições e doenças relacionadas com endotoxina, bem como método para a produção e uso de tais composições.
BRPI0408077-7A 2003-03-05 2004-03-05 composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições BRPI0408077A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45202203P 2003-03-05 2003-03-05
PCT/US2004/006713 WO2004078142A2 (en) 2003-03-05 2004-03-05 Compositions and methods for preventing and treating endotoxin-related diseases and conditions

Publications (1)

Publication Number Publication Date
BRPI0408077A true BRPI0408077A (pt) 2006-02-14

Family

ID=32962682

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408077-7A BRPI0408077A (pt) 2003-03-05 2004-03-05 composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições

Country Status (12)

Country Link
US (1) US20080095786A9 (pt)
EP (1) EP1601661A2 (pt)
JP (1) JP2006519872A (pt)
KR (1) KR20060002795A (pt)
CN (1) CN1780824A (pt)
AU (1) AU2004218358A1 (pt)
BR (1) BRPI0408077A (pt)
CA (1) CA2516629A1 (pt)
MX (1) MXPA05009428A (pt)
NO (1) NO20054346L (pt)
RU (1) RU2005130771A (pt)
WO (1) WO2004078142A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130212A1 (en) * 1999-01-14 2003-07-10 Rossignol Daniel P. Administration of an anti-endotoxin drug by intravenous infusion
US6906042B2 (en) 2000-02-18 2005-06-14 Eisai Co., Ltd. Micelles
EP2338497A1 (en) * 2001-08-10 2011-06-29 Eisai R&D Management Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
WO2007020871A1 (ja) * 2005-08-12 2007-02-22 Astellas Pharma Inc. デプシペプチド含有注射液
KR101457418B1 (ko) * 2009-10-23 2014-11-04 삼성전자주식회사 계층적 부호화 단위의 크기에 따른 비디오 부호화 방법과 그 장치, 및 비디오 복호화 방법과 그 장치
CA2868458A1 (en) * 2012-03-28 2013-10-03 University Of Maryland, Baltimore Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections
AU2019400340A1 (en) * 2018-12-17 2021-05-20 Eisai R&D Management Co., Ltd. Formulation comprising liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750664A (en) * 1995-06-05 1998-05-12 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6437006B1 (en) * 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
MXPA03009995A (es) * 2001-05-09 2004-06-30 Univ Michigan Uso de composiciones para tratar rosacea.

Also Published As

Publication number Publication date
WO2004078142A2 (en) 2004-09-16
US20080095786A9 (en) 2008-04-24
EP1601661A2 (en) 2005-12-07
NO20054346L (no) 2005-11-04
AU2004218358A1 (en) 2004-09-16
WO2004078142A3 (en) 2004-12-23
CA2516629A1 (en) 2004-09-16
MXPA05009428A (es) 2005-12-12
JP2006519872A (ja) 2006-08-31
NO20054346D0 (no) 2005-09-20
RU2005130771A (ru) 2006-01-27
US20060222655A1 (en) 2006-10-05
KR20060002795A (ko) 2006-01-09
CN1780824A (zh) 2006-05-31

Similar Documents

Publication Publication Date Title
BRPI0418031A (pt) inibidores de quinase fosfonato-substituìdos
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
TW200509892A (en) Novel aminobenzophenone compounds
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
ATE529409T1 (de) Verfahren zur herstellung von kristallinen aripiprazolformen
CY1108808T1 (el) Ενωσεις μοτιλιδης
DOP2002000429A (es) Imidazotriazinas
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
UA96115C2 (uk) Спосіб і композиція для лікування амілоїдогенних захворювань
UY28376A1 (es) Agentes terapéuticos
EP1594889A4 (en) NELL PEPTIDE EXPRESSION SYSTEMS AND BONE-MAKING NELL PEPTIDE ACTIVITY
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
EA200801711A1 (ru) Пролекарства возбуждающих аминокислот
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
NI200300045A (es) Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa.
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
TR200200278T2 (tr) Kalsilitik bileşimler
UY27733A1 (es) Derivados de ciclopenteno.
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
PL376149A1 (en) Piperazine and piperidine derivatives for treatment of neurological diseases
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
EP1436279A4 (en) CHEMICAL COMPOUNDS

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: EISAI RANDD MANAGEMENT CO., LTD. (JP)

Free format text: TRANSFERIDO DE: EISAI CO., LTD.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.